Effect of metoprolol on cytokine levels in chronic heart failure - A substudy in the metoprolol controlled-release randomised intervention trial in heart failure (MERIT-HF)

American Heart Journal

Volumn 141, Issue 3, 2001, Pages 418-421

  Gullestad, Lars ^a   Ueland, Thor ^a   Brunsvig, Anne ^a   Kjekshus, John ^a   Simonsen, Svein ^a   Frøland, Stig S ^a   Aukrust, Pål ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOKINE; DIGITOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; METOPROLOL; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE ACTIVATION;

EID: 0035093875     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.112785     Document Type: Article

References (29)

1. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure
2. The Cardiac Insufficiency Bisoprolol study (CIBIS II): A randomized trial
3. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
4. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart
5. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension
6. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the Studies of Left Ventricular Dysfunction (SOLVD)
7. Elevated circulating levels of C-C chemokines in patients with congestive heart failure
8. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
9. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalion heart
10. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes
11. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes
12. Is apoptosis an important pathogenic factor in cardiovascular disease?
13. Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency-possible immunologic and clinical consequences
14. Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogenic bone marrow transplantation
15. The role of cytokines in the failing human heart
16. Role of cytokines in the mechanism of action of amlodipine: The PRAISE heart failure trial. Prospective randomized amlodipine survival evaluation
17. Effect of high- versus lowdose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure
18. Propranolol treatment affects parameters of human immunity
19. Isoproterenol inhibits 11-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages
20. The β2-adrenergic agonist salbutamal is a potent suppressor of established collagen-induced arthritis: Mechanisms of action
21. Regulation of interleukin-10 production by beta-adrenergic agonists
22. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)
23. β1- and β2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: Coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure
24. Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy: Correlation with disease severity and cardiac autoantibodies
25. Perturbation of the T-cell repertoire in patients with unstable angina
26. The role of sensitized T-cells in myocarditis and dilated cardiomyopathy
27. Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats
28. Safety and efficacy of a soluble p75 tumor necrosis factor receptor (Enbrel, Etanercept) in patients with advanced heart failure
29. Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy